Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat Tuberculosis

NCT00816426 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

NIH

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Rifampicin
DRUG: Isoniazid
DRUG: Pyrazinamide
DRUG: Kanamycin
DRUG: Moxifloxacin

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]